Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management
- PMID: 23180176
- PMCID: PMC3764319
- DOI: 10.1007/s00415-012-6736-7
Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management
Abstract
Neurogenic orthostatic hypotension is a distinctive and treatable sign of cardiovascular autonomic dysfunction. It is caused by failure of noradrenergic neurotransmission that is associated with a range of primary or secondary autonomic disorders, including pure autonomic failure, Parkinson's disease with autonomic failure, multiple system atrophy as well as diabetic and nondiabetic autonomic neuropathies. Neurogenic orthostatic hypotension is commonly accompanied by autonomic dysregulation involving other organ systems such as the bowel and the bladder. In the present review, we provide an overview of the clinical presentation, pathophysiology, epidemiology, evaluation and management of neurogenic orthostatic hypotension focusing on neurodegenerative disorders.
Figures
Similar articles
-
Orthostatic hypotension: managing a difficult problem.Expert Rev Cardiovasc Ther. 2015 Nov;13(11):1263-76. doi: 10.1586/14779072.2015.1095090. Epub 2015 Oct 1. Expert Rev Cardiovasc Ther. 2015. PMID: 26427904 Free PMC article. Review.
-
Diagnosing and treating neurogenic orthostatic hypotension in primary care.Postgrad Med. 2015;127(7):702-15. doi: 10.1080/00325481.2015.1050340. Epub 2015 May 27. Postgrad Med. 2015. PMID: 26012731 Review.
-
Orthostatic hypotension: definition, diagnosis and management.J Cardiovasc Med (Hagerstown). 2015 Feb;16(2):75-81. doi: 10.2459/01.JCM.0000446386.01100.35. J Cardiovasc Med (Hagerstown). 2015. PMID: 24933201 Review.
-
Orthostatic Hypotension: JACC State-of-the-Art Review.J Am Coll Cardiol. 2018 Sep 11;72(11):1294-1309. doi: 10.1016/j.jacc.2018.05.079. J Am Coll Cardiol. 2018. PMID: 30190008 Review.
-
Orthostatic hypotension: evaluation and treatment.Cardiovasc Hematol Disord Drug Targets. 2007 Mar;7(1):63-70. doi: 10.2174/187152907780059029. Cardiovasc Hematol Disord Drug Targets. 2007. PMID: 17346129 Review.
Cited by
-
Objective and self-perceived lower limb weakness in Parkinson's disease.Ther Adv Neurol Disord. 2022 Nov 8;15:17562864221136903. doi: 10.1177/17562864221136903. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 36389280 Free PMC article.
-
Autism Spectrum Disorder in Children Is Not Associated With Abnormal Autonomic Nervous System Function: Hypothesis and Theory.Front Psychiatry. 2022 Mar 15;13:830234. doi: 10.3389/fpsyt.2022.830234. eCollection 2022. Front Psychiatry. 2022. PMID: 35370829 Free PMC article.
-
Managing Postural Hypotension in Diabetic Autonomic Dysfunction When Adrenergic Drugs are Contraindicated: Case Report and Review of Literature.Cureus. 2018 Jan 8;10(1):e2039. doi: 10.7759/cureus.2039. Cureus. 2018. PMID: 29541560 Free PMC article.
-
Editorial: Autonomic Neuropathy and Cardiovascular Disease in Aging.J Nutr Health Aging. 2018;22(9):1028-1033. doi: 10.1007/s12603-018-1097-2. J Nutr Health Aging. 2018. PMID: 30379298 Free PMC article. No abstract available.
-
Management of neurogenic orthostatic hypotension in patients with autonomic failure.Drugs. 2013 Aug;73(12):1267-79. doi: 10.1007/s40265-013-0097-0. Drugs. 2013. PMID: 23857549 Review.
References
-
- (1996) Assessment: clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 46:873–880 - PubMed
-
- (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 46:1470 - PubMed
-
- (1988) Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology. Diabetes care 11:592–597 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical